Physician profile
Patrick V Aufiero
NPI 1649295270
$4,572.26
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,412 · 2020: $1,179 · 2021: $1,482 · 2022: $433 · 2023: $66.35.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $46.54 · Education: $19.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $46.54 |
| Education | $19.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $1,063.54 | 2019-2022 | |
| Gilead Sciences, INC. | $702.75 | 2019-2022 | |
| Abbvie INC. | $507.47 | 2019-2023 | Dalvance |
| Merck Sharp & Dohme LLC | $489.73 | 2019-2023 | Delstrigo |
| Janssen Biotech, INC. | $433.02 | 2019-2022 | |
| Paratek Pharmaceuticals, INC. | $381.36 | 2019-2022 | |
| Allergan, INC. | $289.18 | 2019-2020 | |
| Smith+Nephew, INC. | $130.24 | 2019-2022 | |
| Janssen Products, LP | $99.00 | 2019 | |
| Organogenesis INC. | $98.22 | 2019-2021 | |
| Insmed, INC. | $80.27 | 2020-2022 | |
| Theratechnologies INC. | $76.97 | 2019-2021 | |
| Melinta Therapeutics, LLC | $69.25 | 2019-2020 | |
| Astellas Pharma US INC | $28.99 | 2019 | |
| Nabriva Therapeutics, Plc | $28.97 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Scientific Affairs, LLC | $26.82 | 2021-2022 | |
| Tetraphase Pharmaceuticals, INC. | $19.15 | 2019 | |
| Mylan Institutional INC. | $13.78 | 2019 | |
| Emd Serono, INC. | $12.98 | 2019 | |
| Kerecis Limited | $10.65 | 2020 | |
| Aroa Biosurgery Incorporated | $9.92 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Aufiero listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.